Pfizer says a drug-trial review indicates its COVID-19 vaccine is more than 90% effective in preventing the illness. The company, which developed the vaccine with BioNTech, says it could seek government approval later this month to start administering the two-dose vaccine after collecting two months of safety data.
Pfizer: Coronavirus vaccine over 90% effective
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.